RBM39 and ovarian cancer: Levels of CAPER transcripts also are higher in brain cancer (oncomine.org), ovarian cancer [34], and metastatic prostate cancer (GEO profile) and it has been found to contribute to carcinogenesis in mouse models of breast [5] and prostate metastases [35].